Qi Lin Wan
Natural health product licensed in Canada
- Other names
- Qi Lin Pills
- Licence holder
- Guangdong Taiantang Pharmaceutical CO., LTD
- NPN or DIN-HM
- 80066851
- Status
- Active licence
- Licence date
- 9 February 2016
- Revision date
- 16 October 2020
- Form
- Pilule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Dioscorea oppositifolia L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Reynoutria multiflora Source : Tubercule Extract : Matériel brut sec Extraction ratio : 3.224:1 Dry plant equivalent : 21.6 mg | 6.7 mg | Not calculated |
| Citrus reticulata Source : Fruit pericarp Extract : Matériel brut sec Extraction ratio : 3.225:1 Dry plant equivalent : 16.8 mg | 5.21 mg | Not calculated |
| Curcuma kwangsiensis Source : Tubercule Extract : Matériel brut sec Extraction ratio : 3.226:1 Dry plant equivalent : 12 mg | 3.72 mg | Not calculated |
| Codonopsis pilosula Source : Racine Extract : Matériel brut sec Extraction ratio : 3.224:1 Dry plant equivalent : 21.6 mg | 6.7 mg | Not calculated |
| Lycium barbarum Source : Fruit Extract : Matériel brut sec Extraction ratio : 3.225:1 Dry plant equivalent : 16.8 mg | 5.21 mg | Not calculated |
| Paeonia lactiflora Source : Racine Extract : Matériel brut sec Extraction ratio : 3.221:1 Dry plant equivalent : 14.4 mg | 4.47 mg | Not calculated |
| Dioscorea oppositifolia Source : Rhizome Extract : Matériel brut sec Extraction ratio : 3.221:1 Dry plant equivalent : 14.4 mg | 4.47 mg | Not calculated |
| Eclipta prostrata Source : Sommité Extract : Matériel brut sec Extraction ratio : 3.221:1 Dry plant equivalent : 14.4 mg | 4.47 mg | Not calculated |
| Epimedium brevicornu Source : Feuille Extract : Matériel brut sec Extraction ratio : 3.226:1 Dry plant equivalent : 12 mg | 3.72 mg | Not calculated |
| Cynomorium songaricum Source : Tige Extract : Matériel brut sec Extraction ratio : 3.221:1 Dry plant equivalent : 14.4 mg | 4.47 mg | Not calculated |
| Cuscuta chinensis Source : Semence(s) Extract : Matériel brut sec Extraction ratio : 3.221:1 Dry plant equivalent : 19.2 mg | 5.96 mg | Not calculated |
| Rubus chingii Source : Fruit Extract : Matériel brut sec Extraction ratio : 3.225:1 Dry plant equivalent : 16.8 mg | 5.21 mg | Not calculated |
| Salvia miltiorrhiza Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 3.221:1 Dry plant equivalent : 14.4 mg | 4.47 mg | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Matériel brut sec Extraction ratio : 3.221:1 Dry plant equivalent : 14.4 mg | 4.47 mg | Not calculated |
| Morus alba Source : Fruit Extract : Matériel brut sec Extraction ratio : 3.225:1 Dry plant equivalent : 16.8 mg | 5.21 mg | Not calculated |
Non-medicinal ingredients
Charbon
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 80 Pilule | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Traditional Chinese medicine used to nourish the kidney, replenish qi to nourish blood, used for aching and weakness in the lower back and leg, nocturnal emissions, spermatorrhea, cold and thin sperm, and lassitude due to deficiencies of qi and blood.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptom develop, discontinue use and consult a health care practitioner. Consult a health care practitioner prior to use if you have liver disorder. Discontinue use and consult a health care practitioner if yellowing of the skin or whites of the eyes, dark urine, nausea, vomiting, unusual tiredness, weakness, stomach or abdominal pain, and/or loss of appetite, as these may be symptoms of liver disease. If you are taking prescription medication, consult a health care practitioner prior to use.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80066851
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging